BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

Typically moves ±3.55% on earnings
EARNINGS ANALYTICS
search

BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) has a 4-report earnings history dating back to Nov 12, 2025. Its average absolute post-earnings move is ±3.55%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +5.72% (Mar 05, 2026) and its largest decline was -4.81% (Nov 12, 2025).

Earnings reactions

How BBOT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

4

Avg Abs. Movement

±3.55%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 11, 2026 ☽ POST +2.45% open_in_new
May 12, 2026 ☽ POST -1.23% open_in_new
Mar 05, 2026 ☽ POST +5.72% open_in_new
Nov 12, 2025 ☽ POST -4.81% open_in_new
event

Earnings Count

4

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.55%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

Frequently asked about BBOT earnings

How much does BBOT stock move after earnings? expand_more

Over 4 reports, BBOT has moved an average of ±3.55% the session after earnings, closing higher 50.0% of the time.

What was BBOT's biggest post-earnings move? expand_more

BBOT's largest post-earnings gain on record was +5.72% on Mar 05, 2026, and its largest decline was -4.81% on Nov 12, 2025.

Where can I find BridgeBio Oncology Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of BridgeBio Oncology Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.